Here are relevant reports on : protein-therapeutics-market
-
Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of Administration (Parenteral), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecasts to 2025
The global osteoarthritis therapeutics market growth is primed to transition from USD 7.3 billion in 2020 to USD 11.0 million by 2025, showcasing a strong CAGR of 8.7%.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) & Region - Global Forecast to 2028
The global antibody therapeutics market, valued at US$217.6 billion in 2022, stood at US$247.3 billion in 2023 and is projected to advance at a resilient CAGR of 14.1% from 2023 to 2028, culminating in a forecasted valuation of US$479.0 billion by the end of the period. Growth in the antibody therapeutics market is mainly driven by factors such as growing advancements in antibody engineering for development of novel therapeutics, growing R&D activities among others
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Bioconjugation Market by Product (Consumables, Instruments (Chromatography, Spectrometry)), Service (Conjugation, Analytical), Technique (Chemical, Click Chemistry), Biomolecule (Antibodies), Application (Therapeutics (ADC), R&D) - Global Forecast to 2029
The global bioconjugation market, valued at US$4.78 billion in 2023, stood at US$5.27 billion in 2024 and is projected to advance at a resilient CAGR of 15.6% from 2024 to 2029, culminating in a forecasted valuation of US$10.86 billion by the end of the period. The bioconjugation market is experiencing significant growth with the advancement of bioconjugation technologies, which increase precision, efficacy, and safety in therapeutic & diagnostic applications.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Medical Gas and Equipment Market by Type (Pure Medical Gases/Mixtures), Medical Gas Equipment (Flowmeter, Medical Air Compressor)), Application (Therapeutics (Respiratory), Diagnostics), End User (Hospitals, Home Healthcare) - Global Forecast to 2029
The global medical gas and equipment market, valued at US$17.65 billion in 2022, stood at US$19.90 billion in 2023 and is projected to advance at a resilient CAGR of 5.8% from 2023 to 2029, culminating in a forecasted valuation of US$26.44 billion by the end of the period. The market is expanding significantly due to rising respiratory illnesses that necessitate frequent medical gas treatment and growing demand for effective and safe gas delivery systems. Increased emphasis on home healthcare services and regulatory support for safer gas delivery methods are expected to boost market growth.
- Published: September 2024
- Price: $ 7150
- TOC Available:
-
Centesis Catheters Market Size by Type (Small and Large bore), Procedure (Paracentesis, Thoracentesis, Amniocentesis), Application (Diagnosis, Therapeutics and Palliative care), End user (Hospitals, Ambulatory surgery centers), Region - Global Forecasts to 2025
The size of centesis catheters market in terms of revenue was estimated to be worth USD 426 million in 2019 and is poised to reach USD 633 million by 2025, growing at a CAGR of 6.8% from 2019 to 2025. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Human Microbiome Drugs Market by Type (Live Biotherapeutic Products, Fecal Microbiota-derived Therapeutics), Disease (Gastrointestinal, Infectious), End User (Hospitals, Clinics, Long-term Care) - Global Forecast to 2031
The human microbiome drugs market is expected to reach USD 2.13 billion by 2031, up from USD 0.35 billion in 2025, at a CAGR of 35.2%. The Key Players include Seres Therapeutics (US), Ferring B.V. (Switzerland), MaaT Pharma (France), BiomeBank (Australia), Infant Bacterial Therapeutics AB (Sweden), and Finch Therapeutics Group, Inc. (US)
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Wireless Devices Market for Medical by Technology (BT/BLE, Wi-Fi, ZigBee, ANT+), Component (Sensors, ICs, Processors), Application (Monitoring, Medical Therapeutics, Diagnosis, Fitness & Wellness), and Geography – Global Forecast to 2020
Wireless portable medical devices, which are widely used in applications such as monitoring, medical therapeutics, diagnosis, and fitness and wellness, have proved to be very useful to cater to the growing need of advanced healthcare services. Portable medical electronics have proved to be a boon to medical science as it plays an important role in overall diagnosis and patient monitoring activities.
- Published: December 2014
- Price: $ 4950
- TOC Available:
-
Meat Substitutes Market Size, Share, Industry Growth, Trends Report by Product (Tofu, Tempeh, Textured Vegetable Protein, Seitan, Quorn and Other Product), Source (Soy Protein, Wheat Protein, Pea Protein and Other Sources), Types ( Concentrates, Isolates and Textured), Form (Solid, Liquid), Category (Frozen, Refrigerated and Shelf Table) and Region (North America, Europe, Asia Pacific, Rest of the World) - Forecast 2027
According to MarketsandMarkets, the meat substitute market is projected to reach USD 4,041.3 million by 2027, recording a CAGR of 13.5% during the forecast period. The key players in the market are ADM (US), Ingredion Incorporated (US), DuPont (US), Kerry Group (Ireland), and Roquette Frères (France).
- Published: September 2021
- Price: $ 4950
- TOC Available:
-
Soy Protein Ingredients Market by Type (Soy Protein Concentrates, Soy Protein Isolates, Textured Soy Protein, and Soy Flours), Application (Food and Feed), Form (Dry and Liquid), Nature, Function, and Region - Global Forecast to 2027
The global soy protein ingredients market is projected to reach USD 10.8 billion by 2027, recording a CAGR of 7.0% during the forecast period. The key players in this market include ADM (US), Wilmar International Co., Ltd. (Singapore), Cargill, Incorporated (US), CHS, Inc. (US), and Fuji Oil Holdings Inc (Japan)
- Published: January 2023
- Price: $ 4950
- TOC Available:
-
Protein A Resin Market by Product (Bulk Resin, Lab-scale Columns), Source (Recombinant Protein A), Matrix Type (Agarose-Based Protein A), Application (Monoclonal Antibody Purification, FC-Fusion Protein Purification) & End User - Global Forecast to 2030
The global protein A resin market, valued at US$1.4 billion in 2024, stood at US$1.5 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$2.0 billion by the end of the period. The market's growth is connected to increased outsourced services through CDMOs, as major companies expand multi-plant biomanufacturing capacities in developed markets.
- Published: August 2025
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
